AKT1 and neoplasm: OC suppresses PI3K/AKT and MAPK/ERK signaling in tumor-associated endothelial cells, reducing phosphorylated AKT (Ser473) and ERK1/2 (Thr202/Tyr204) by 65% and 55%, respectively, at 25 μM [123].